F7G

Thorne HealthTech DB:F7G Stock Report

Last Price

€5.90

Market Cap

€313.2m

7D

19.9%

1Y

n/a

Updated

08 Aug, 2022

Data

Company Financials +
F7G fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance2/6
Financial Health4/6
Dividends0/6

F7G Stock Overview

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.

Thorne HealthTech, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Thorne HealthTech
Historical stock prices
Current Share PriceUS$5.90
52 Week HighUS$6.70
52 Week LowUS$3.90
Beta0
1 Month Change30.53%
3 Month Change-3.28%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO38.86%

Recent News & Updates

Shareholder Returns

F7GDE Personal ProductsDE Market
7D19.9%-0.8%1.4%
1Yn/a-7.2%-19.6%

Return vs Industry: Insufficient data to determine how F7G performed against the German Personal Products industry.

Return vs Market: Insufficient data to determine how F7G performed against the German Market.

Price Volatility

Is F7G's price volatile compared to industry and market?
F7G volatility
F7G Average Weekly Movement7.9%
Personal Products Industry Average Movement5.4%
Market Average Movement5.7%
10% most volatile stocks in DE Market10.7%
10% least volatile stocks in DE Market2.8%

Stable Share Price: F7G is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: F7G's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1984496Paul Jacobsonhttps://www.thorne.com

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health.

Thorne HealthTech, Inc. Fundamentals Summary

How do Thorne HealthTech's earnings and revenue compare to its market cap?
F7G fundamental statistics
Market CapUS$320.09m
Earnings (TTM)US$8.72m
Revenue (TTM)US$195.43m

36.7x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
F7G income statement (TTM)
RevenueUS$195.43m
Cost of RevenueUS$91.20m
Gross ProfitUS$104.23m
Other ExpensesUS$95.51m
EarningsUS$8.72m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 09, 2022

Earnings per share (EPS)0.17
Gross Margin53.34%
Net Profit Margin4.46%
Debt/Equity Ratio1.1%

How did F7G perform over the long term?

See historical performance and comparison